Prestige Consumer Healthcare Inc. buy Oppenheimer Holdings Inc.
Start price
13.02.25
/
50%
€80.50
Target price
13.02.26
€89.17
Performance (%)
-31.06%
End price
14.02.26
€55.50
Summary
This prediction ended on 14.02.26 with a price of €55.50. Massive losses of -31.06% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has a follow-up prediction for Prestige Consumer Healthcare Inc. where he still thinks Prestige Consumer Healthcare Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.909% | 0.909% | -31.902% |
| iShares Core DAX® | 0.193% | -1.216% | 8.843% |
| iShares Nasdaq 100 | -1.353% | -5.307% | -1.141% |
| iShares Nikkei 225® | -0.426% | 7.319% | 27.580% |
| iShares S&P 500 | -1.008% | -3.400% | -0.222% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $87.00 to $93.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€53.00
21.10.25
21.10.25
€61.83
21.10.26
21.10.26
4.72%
17.02.26
17.02.26
